Every 8-K that THE CANNABIST CO HLDG (CBSTF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CBSTF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CBSTF filings page.
The Cannabist Company Holdings Inc. completed the previously announced sale of substantially all assets related to its Delaware operations to Arboretum PermitCo LLC for total consideration of $16.5 million.
The consideration includes $14.025 million payable at closing, subject to working capital adjustments, and $2.475 million held in escrow for up to twelve months under specified release conditions. The company is operating under Companies’ Creditors Arrangement Act proceedings in Canada with related Chapter 15 relief in the U.S. Following the closing, the Audit Committee determined the company cannot continue SEC periodic reporting without unreasonable effort and expense, and it does not intend to file its Form 10-K for 2025 or any future Form 10-Qs.
The Cannabist Company Holdings Inc. reported that President Jesse Channon resigned his employment position effective April 1, 2026. Channon, who joined the company in 2019 and later became President, will continue supporting the business as a non-employee consultant under a new agreement.
Under this Consulting Engagement Agreement, he will receive $10,000 per month to provide corporate services from April 2, 2026 through July 3, 2026, with the term extendable or terminable pursuant to its terms. The agreement includes customary confidentiality provisions and is filed as Exhibit 10.1.
The Cannabist Company Holdings Inc. has entered into binding deals to sell its Ohio and Delaware operations and begun court-supervised restructuring in Canada and the U.S. The Ohio business is being sold to Holistic Industries for $47 million, including $34.5 million in cash at closing and a $12.5 million promissory note, subject to adjustments. The Delaware assets are being sold to Parma Holdco for $16.5 million in cash, part of which will be held in escrow for indemnities.
The company has signed a support agreement with senior secured noteholders holding around 60% of its notes to back these transactions and additional sales, including operations in other states for at least $25 million in cash plus a $25 million note, while winding down remaining markets. Cannabist and a Canadian affiliate have commenced proceedings under the Companies’ Creditors Arrangement Act in Ontario and plan a related Chapter 15 case in the U.S. A court-appointed monitor will oversee the process, operations in New York have ceased, Pennsylvania is being wound down, and trading on Cboe Canada is expected to be halted with a potential delisting review.
The Cannabist Company Holdings Inc. entered into an amended forbearance arrangement with an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028. The noteholders agreed to further extend their agreement to forbear from exercising rights and remedies under the governing indenture and applicable law until March 25, 2026, giving the company a short additional period of relief while it addresses its obligations under these secured notes.
The Cannabist Company Holdings Inc. entered into an amendment to its existing forbearance arrangements with holders of its 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028. These noteholders agreed to extend their commitment to forbear from exercising rights and remedies under the indenture and applicable law until March 17, 2026, giving the company additional time under the current agreement.
The Cannabist Company Holdings Inc. entered into an amended arrangement with the holders of its 9.25% Senior Secured Notes due December 31, 2028 and its 9.00% Senior Secured Convertible Notes due December 31, 2028. These noteholders agreed to extend their forbearance agreement and refrain from exercising rights and remedies under the governing indenture and applicable law until March 6, 2026.
The company emphasizes that statements about plans, strategies and future events are forward-looking and subject to significant risks and uncertainties, directing investors to its Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended September 30, 2025 for detailed risk factors.
The Cannabist Company Holdings Inc. entered into a further agreement with an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and its 9.00% Senior Secured Convertible Notes due December 31, 2028. These noteholders agreed to extend their forbearance from exercising rights and remedies under the governing indenture and applicable law until February 27, 2026. This short-term extension gives the company additional time while it addresses its obligations under these senior secured notes.
The Cannabist Company Holdings Inc. disclosed that an ad hoc group of holders of its 9.25% Senior Secured Notes due December 31, 2028 and 9.00% Senior Secured Convertible Notes due December 31, 2028 has agreed to extend a forbearance arrangement.
These noteholders, party to a previously announced forbearance agreement, will continue to refrain from exercising rights and remedies under the governing indenture and applicable law until February 20, 2026. The company also includes standard forward-looking statement language, directing readers to risk factors in its Form 10-K for 2024 and Form 10-Q for the quarter ended September 30, 2025.
The Cannabist Company Holdings Inc. completed the sale of all equity interests in its Virginia cannabis subsidiary to an affiliate of Millstreet Credit Fund LP for total consideration of $130 million. The package includes $117.5 million in cash at closing and $12.5 million held in escrow, part of which depends on post-closing adjustments and indemnification over nine months.
The Virginia business comprises 5 operating retail locations, 1 additional store in development, and about 82,000 square feet of cultivation and production capacity in the Richmond area. In anticipation of closing, the company initiated partial redemptions of its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes.
The company expects to redeem on February 13, 2026, $84,488,000 principal of its 9.25% Senior Secured Notes and $6,469,000 principal of its 9.00% Senior Secured Convertible Notes at 100% of principal plus accrued interest, using proceeds from the Virginia asset sale.
The Cannabist Company Holdings Inc. disclosed that it did not make the interest payments due December 31, 2025 on its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes, leading to an event of default after a 30‑day grace period under the indenture.
On January 30, 2026, the company entered into a forbearance agreement with an ad hoc group of noteholders holding more than 75% of the Notes’ aggregate principal amount. These noteholders agreed to temporarily refrain from enforcing their rights related to the missed interest payments until February 17, 2026, while the company evaluates strategic alternatives, including possible asset sales and other financial or restructuring options.
The Cannabist Company Holdings Inc. plans a conditional partial redemption of its 9.25% Senior Secured Notes due 2028 and 9.00% Senior Secured Convertible Notes due 2028, with total redemption payments capped at $97,000,000.
If a previously announced equity purchase agreement closes on or before February 13, 2026, the company will redeem $84,488,000 principal of the 9.25% Notes and $6,469,000 principal of the 9.00% Convertible Notes, plus accrued interest. If the condition is met after February 13, 2026, the trustee will determine redemption amounts so that payments do not exceed $97,000,000. If the condition is not satisfied within 60 days of January 29, 2026, the redemption notice becomes void.
The Cannabist Company Holdings Inc. disclosed that it did not make the interest payment due on its 9.25% Senior Secured Notes due December 31, 2028 and its 9.0% Senior Secured Convertible Notes due December 31, 2028. Under the indenture for these notes, the company has a 30‑day grace period to make the payment before the missed payment becomes an event of default.
The company states it is withholding the payment to enhance short‑term financial flexibility and preserve liquidity while a special committee of independent directors reviews strategic alternatives. That review follows the recently announced sale of its Virginia assets to an affiliate of Millstreet Credit Fund LP and includes possible additional asset sales, mergers, or other strategic, financial or restructuring transactions or proceedings.
The Cannabist Company Holdings Inc. agreed to sell its subsidiary Green Leaf Medical of Virginia, LLC to Parma Holdco LLC for $130 million. The consideration includes $117.5 million payable at closing and an $12.5 million escrow that can be used for purchase price adjustments and indemnification over nine months. Buyer will also place a $23.7 million deposit in escrow shortly after signing. Closing is subject to regulatory approvals and consents from holders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and 9.0% Senior Secured Convertible Notes due December 31, 2028.
The Company previously agreed to sell Green Leaf Virginia to Curaleaf, Inc. but terminated that agreement after determining the Parma Holdco proposal was superior. In connection with the termination, the Company must pay Curaleaf a $3.3 million break-up fee. The new agreement includes an outside closing date of February 27, 2026, customary termination rights, indemnification terms, and an 18‑month non‑compete and non‑solicitation in Virginia for the Company and the selling member.
The Cannabist Company Holdings Inc. approved a new key employee retention bonus plan to support its ongoing strategic review process. The plan replaces a prior transaction-based bonus program and is designed to encourage leaders to stay with the company through critical phases of this review.
The Retention Bonus Plan establishes an aggregate cash bonus pool of approximately $2.74 million for designated employees and officers. Under individual retention agreements, CEO David Hart is eligible for a total cash bonus of $800,000 payable in monthly installments through the last payroll date in November 2026, and President Jesse Channon is eligible for $500,000 payable in monthly installments through the last payroll date in March 2026, subject to continued employment and other conditions.
If an employee is terminated without cause, or in the event of death or disability, any unpaid installments become payable in a lump sum after termination, subject to a release agreement. If employment ends for other reasons, or notice of termination has been given or received before a payment date, remaining unpaid installments are forfeited.
The Cannabist Company Holdings Inc. is amending a recent report to attach full copies of its equity purchase agreement and related documents for the sale of its Virginia subsidiary to Curaleaf. Under the agreement, Curaleaf will buy all equity of Green Leaf Medical of Virginia for total consideration of $110 million, including $80 million in cash at closing, $20 million in deferred cash and a $10 million promissory note bearing 6% annual interest and maturing one year after closing.
The deferred payment depends on adult-use sales beginning at six specified Virginia retail locations within defined timeframes and expires if conditions are not met within seven years. The deal includes a 15-business-day go-shop period through December 22, 2025, an outside closing date of February 27, 2026, and a potential $3.3 million break-up fee to Curaleaf in certain termination scenarios. Cannabist will also reimburse up to $350,000 of Curaleaf’s transaction expenses shortly after signing.
The Cannabist Company Holdings Inc. entered into a material agreement to sell all of the equity of its Virginia subsidiary, Green Leaf Medical of Virginia, LLC, to a Curaleaf, Inc. subsidiary for total consideration of $110 million. The consideration includes $80 million in cash at closing, $20 million in deferred cash, and a $10 million promissory note bearing 6% annual interest and maturing one year after closing, all subject to various working capital, debt and expense adjustments and indemnification set‑offs.
The deferred payment depends on the timing of first adult-use sales at six specified Virginia retail locations and expires if conditions are not satisfied within seven years of closing. The agreement includes a go‑shop period through December 22, 2025, an outside closing date of February 27, 2026, required consents and lien releases from holders of the Company’s senior secured notes, and a $3.3 million break‑up fee payable to the buyer in certain termination scenarios, plus up to $350,000 of non‑refundable buyer transaction expenses.
The Cannabist Company Holdings Inc. (CBSTF) reported that its Chief Financial Officer, Derek Watson, resigned his employment position on November 15, 2025 but will continue to serve as CFO as a non-employee consultant. The company states that his transition is not due to any disagreement over its financial statements, internal controls, operations, policies or practices.
Under a new CFO Consulting Agreement, Mr. Watson will allocate a minority of his working time to the company and receive $15,000 per month. He remains eligible for the 2025 executive bonus plan based on performance from January 1, 2025 to November 15, 2025. The consulting term runs from November 16, 2025 to May 15, 2026 and can be ended by either party, with the company able to pay an amount equal to two months of fees in lieu of notice.
The Cannabist Company Holdings Inc. furnished a current report to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1.
The information under Item 2.02 and Exhibit 99.1 is being furnished, not deemed filed under the Exchange Act or incorporated by reference unless expressly stated.
The Cannabist Company Holdings Inc. reported that co-founder Michael Abbott has resigned from its Board of Directors. Abbott, who previously served as Executive Chairman and Chair of the Board, informed the Board of his decision on October 3, 2025, and his resignation was effective the same day. The company states that his departure is to pursue other personal and professional commitments and that it did not arise from any dispute or disagreement regarding the company’s operations, policies, or practices.
The Cannabist Company Holdings Inc. reported the results of its annual general meeting of shareholders held virtually on September 26, 2025. Shareholders elected seven directors to serve until the next annual meeting or until their successors are chosen, including Michael Abbott, Jeff Clarke, David Hart, Julie Hill, Peter Lee, Thomas Lynch, and Jonathan P. May. Support levels varied by nominee, with Peter Lee and Thomas Lynch each receiving 146,958,000+ votes in favor.
Shareholders also approved the re-appointment of PKF O’Connor Davies, LLP as the Company’s auditor until the next annual meeting. The auditor proposal received 256,774,373 votes for, 0 votes against, and 4,201,615 abstentions, indicating strong shareholder support for continuing with the current audit firm.